Todd A. Zigrang, MBA, MHA, FACHE, CVA, ASA, ABV, president of Health Capital Consultants, discusses accountable care organizations (ACOs) and the move toward value-based care models.
Todd A. Zigrang, MBA, MHA, FACHE, CVA, ASA, ABV, president of Health Capital Consultants, discusses accountable care organizations (ACOs) and the move toward value-based care models.
Transcript
How do ACOs fit into the overall shift to value-based care?
Value-based care encompasses a broad variety of payment options and models in which health care providers are incentivized to provide better care at lower costs. So ACOs are just one of many different models that fit into value-based care.
We have the providers such as physician groups, hospitals, other outpatient facilities—they take responsibility for the costs, quality, and most importantly, care coordination of its patients. ACOs were created, in a way, to push the industry away from fee-for-service medicine towards value-based care. So I think when we think about ACOs, that's probably the first stepping stone we saw with the Affordable Care Act towards value-based care.
Technically, when I think of value-based care and value, it's quality over cost, that equation. So everything I do in valuation—which is why I'm speaking at the conference: to talk about the valuation in the appraisal of ACOs—I think of some kind of mathematical equation. So ACOs, models, they don't have a universal definition of value, which kind of makes it challenging for ACOs, to continue generating success, if the target by which they're measured constantly moves from year to year.
But those of us in the industry, we kind of recognize that ACOs are a step along a path towards value-based care. I don't think that they'll be the end-all destination. That destination is years and years away, as we've seen how long it's taken to get to this point. I've been in health care for almost 30 years now, and I recall the Clinton administration moving into health care reform. And here we are, still talking about, they're still trying to get there.
Study Highlights Significant Increases in Utilization, Spending on DMD Drugs in Medicaid
May 17th 2024The findings add to recent research on the growing utilization, expenditure, and prices of Duchenne muscular dystrophy (DMD) therapies in the current landscape, an area health care policy could potentially address.
Read More
Frameworks for Advancing Health Equity: Urban Health Outreach
May 9th 2024In the series debut episode of "Frameworks for Advancing Health Equity," Mary Sligh, CRNP, and Chelsea Chappars, of Allegheny Health Network, explain how the Urban Health Outreach program aims to improve health equity for individuals experiencing homelessness.
Listen
ATS 2024: Bridging the Past, Present, and Future of Respiratory Care
May 16th 2024The application of artificial intelligence in medicine is anticipated as a highlight of ATS 2024, with sessions exploring its applications in research, radiological interpretation, and pediatric pulmonology.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Bleeds and Resource Use in Hemophilia B: Retrospective Observational Study
May 15th 2024This real-world US study describes individuals with hemophilia B who experience bleeds despite factor replacement therapy and quantifies the associated comorbidity and health care resource utilization burden.
Read More